- FOCUS-AbbVie’s Humira gets a U.S. rival, but costs could stay high Yahoo! Voices
- America’s top-selling drug Humira loses monopoly status Yahoo Finance
- Amgen aims to make the most of Amjevita’s head start amid broader biosim lull, Lumakras miss FiercePharma
- Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar Yahoo! Voices
- First Humira Biosimilar Launches in US Medscape
- View Full Coverage on Google News
Source link
